Advertisement
Advertisement
U.S. markets open in 5 hours 25 minutes
Advertisement
Advertisement
Advertisement
Advertisement

BioDelivery Sciences International, Inc. (BDSI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.7200+0.0300 (+0.81%)
At close: 04:00PM EST
3.6700 -0.05 (-1.34%)
After hours: 07:56PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close3.6900
Open3.6400
Bid0.0000 x 3100
Ask0.0000 x 4000
Day's Range3.4900 - 3.7300
52 Week Range2.5000 - 4.6800
Volume2,024,771
Avg. Volume1,648,090
Market Cap367.521M
Beta (5Y Monthly)0.86
PE Ratio (TTM)12.83
EPS (TTM)0.2900
Earnings DateMar 08, 2022 - Mar 14, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.71
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
97% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for BDSI

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • BioDelivery Sciences Internatio
    Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total sales are generated in the United States.
    Rating
    Fair Value
    Economic Moat
    17 hours agoMorningstar
View more
  • Motley Fool

    Why Shares of BioDelivery Sciences International Jumped 12.2% on Monday

    Shares of the small pharmaceutical company, which focuses on pain management, have been rising since it released updated guidance late last week.

  • Zacks

    BioDelivery (BDSI) Stock Up on Raised Guidance for 2021

    BioDelivery Sciences International (BDSI) raises its financial guidance for full-year 2021. BDSI expects sales at the high end of its previous guidance.

  • GlobeNewswire

    BioDelivery Sciences Expects 2021 Revenue at the High End of Full Year Guidance

    Total 2021 Net Revenue expected in the range of $165 -$167 million, as compared to previous guidance of $162-$167 million BELBUCA 2021 Net Sales expected to be in the range of $147 -$148 million, as compared to previous guidance of $144-$148 million 2021 EBITDA expected to be in the $40 - $45 million range as compared with previous guidance of <$40 million RALEIGH, N.C., Jan. 20, 2022 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a growing specialty pharmaceutical

Advertisement
Advertisement